Background {#Sec1}
==========

Due to the reduced ability with age to mount an adequate response to pathogenic insults \[[@CR1]\], older adults are more susceptible to bacterial infections. Urinary tract infection (UTI) and pneumonia are two common causes of emergency hospital admissions in older adults \[[@CR2]\] and cost the NHS £316 million and £235 million, respectively \[[@CR3]\].

Serious bacterial infections often present atypically in older adults, creating a diagnostic challenge for clinicians. Fever and other symptoms and signs typically associated with bacterial infections in younger patients may be absent in older adults \[[@CR4]\].

The value of biomarkers in diagnosing serious infection in older adults remains uncertain. Older patients hospitalised with community acquired pneumonia (CAP) mount a significantly lower C-reactive protein (CRP) response compared to younger patients, even with more severe disease \[[@CR5]\]. Asymptomatic bacteriuria is common in older adults; \[[@CR6]\] a positive urine culture could lead to over-treatment \[[@CR7]\], antimicrobial side effects, and rising levels of antibiotic resistance.

There is limited official guidance to help clinicians decide which biomarkers help diagnose bacterial infections in older adults. The Scottish Intercollegiate Guidelines Network (SIGN) recognises that bacteriuria may be so common in the older population that urine culture "ceases to be a diagnostic test \[[@CR8]\]." They advise against the use of urine dipstick testing \[[@CR9]\], however, there is limited evidence as to which tests, if any, are useful.

Therefore, the aim of this review was to systematically review published evidence to determine the value of biomarkers (blood, urinary and salivary) for diagnosing serious bacterial infections in older adults in ambulatory care settings.

Methods {#Sec2}
=======

The protocol was registered on PROSPERO (CRD42018084523). We used methods similar to those published in previous systematic reviews \[[@CR4], [@CR10]\] and reported the study according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA, see Additional file [1](#MOESM1){ref-type="media"}).

Search strategy {#Sec3}
---------------

We searched Medline, Embase and Web of Science and the Cochrane Library, from inception to January 2018 (See Additional file [2](#MOESM2){ref-type="media"} for full search strategy). We searched Google Scholar for internet proceedings and hand-searched the bibliography of relevant systematic reviews and retrieved articles. Five reviewers (OAG, EAS, GCR, IJO and NB) independently determined eligibility with disagreements resolved through discussion.

Inclusion criteria {#Sec4}
------------------

We included observational studies measuring the diagnostic accuracy of a biomarker or combination of biomarkers for diagnosing serious bacterial infections, and providing a reference standard for confirming diagnosis. We defined serious bacterial infections as sepsis (including bacteraemia), pneumonia (excluding infective exacerbations of COPD and asthma), UTI, skin and soft tissue infection (including cellulitis), intra-abdominal infection (cholecystitis, appendicitis, diverticulitis and abscesses), bacterial meningitis, bacterial infective endocarditis and active tuberculosis \[[@CR11]\]. Studies have shown these infections cause increased morbidity and mortality in older adults \[[@CR11], [@CR12]\].

Included studies had to provide sufficient information to enable extraction of data into two by two tables, allowing calculation of diagnostic accuracy measures. Studies needed to contain a minimum of 10 participants. We included adults aged ≥65 years who at the time of study inclusion were symptomatic with undifferentiated illness. Studies including younger participants were included when age-stratified analyses could be performed for older adults. Studies conducted in outpatient settings (including emergency departments, general practice and outpatient clinics) were eligible for inclusion.

Exclusion criteria {#Sec5}
------------------

We excluded studies that were conducted in immunosuppressed participants (e.g. active cancer or receiving chemotherapy) and conducted in developing countries. We also excluded studies in which the index test and reference standard were not performed during the illness episode of the participant. We excluded studies that selected patients on the basis that they all shared a particular co-morbidity. Studies with non-human subjects; and systematic reviews, case reports, case series, case control studies and conference abstracts were excluded. Systematic reviews were used as a point of reference. The exclusion are similar those that have been previously published \[[@CR4], [@CR10]\].

Quality assessment {#Sec6}
------------------

Three reviewers \[OAG, GCR and IJO\] independently assessed study quality using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool \[[@CR13]\]. Disagreements were resolved through discussion; where controversy remained, a third reviewer (CJH) arbitrated.

Data extraction and analysis {#Sec7}
----------------------------

Three reviewers (OAG, GCR and IJO) extracted data independently and in duplicate from included studies into two by two tables. Discrepancies were resolved by discussion. If no consensus could be reached a third reviewer (CK) arbitrated.

We used similar data extraction and analysis methods to a previous diagnostic test accuracy review assessing the value of laboratory tests in identifying serious infections in febrile children \[[@CR14]\]. We calculated positive and negative likelihood ratios (+ve LR and --ve LR, respectively) with their 95% confidence intervals, and the pre- and post-test probabilities for each biomarker. A continuity correction of 0.5 was added to empty cells, to ensure calculations were possible \[[@CR15]\].

We pre-specified meta-analysis when a biomarker was reported by four or more studies for a particular infection \[[@CR14]\], but we had insufficient data to do this. Therefore, results are presented in narrative and on dumbbell plots created in Microsoft Excel (Redmond, WA). Within the plots, we present the pre-test probability of infection (prevalence of infection in the study), and the post-test probability given a positive or negative test result.

Results {#Sec8}
=======

We identified 6,858 non-duplicate results and 463 eligible studies. After full text screening, 11 studies \[[@CR16]--[@CR26]\] met the inclusion criteria (see Fig. [1](#Fig1){ref-type="fig"}). Details of these studies are shown in Table [1](#Tab1){ref-type="table"}. Four studies \[[@CR16], [@CR20], [@CR22], [@CR23]\] assessed UTI and four \[[@CR17], [@CR19], [@CR21], [@CR24]\] assessed bacteraemia. Two studies \[[@CR18], [@CR26]\] assessed 'bacterial infections' and one \[[@CR25]\] assessed intra-abdominal bacterial infections. Eight studies were of prospective diagnostic accuracy design \[[@CR16]--[@CR18], [@CR20]--[@CR22], [@CR24], [@CR26]\], two were retrospective \[[@CR19], [@CR25]\] and one was a prospective cohort study \[[@CR23]\]. There were 11,034 participants included in the studies (range 23 to 9,862). Seven studies were conducted in the emergency department (ED) \[[@CR16], [@CR17], [@CR19], [@CR20], [@CR24]--[@CR26]\], and one each in geriatrics clinics \[[@CR18]\], a medical centre \[[@CR21]\], a day hospital \[[@CR22]\] and nursing homes \[[@CR23]\]. We did not find any eligible studies assessing the use of salivary biomarkers.Fig. 1Flow chart showing the process for identification of studies eligible for inclusionTable 1Characteristics of included studiesAuthor, year and countryStudy TypeStudy SettingNumber of participantsAge (Years)Study DurationBacterial Infection(s) investigatedReference testCaterino et al. (2015), USA \[[@CR16]\]Diagnostic accuracy studyED2365 years and aboveN/AUTIUrine cultureCaterino et al. (2004), USA \[[@CR17]\]Diagnostic accuracy studyED10865--100N/ABacteraemiaBlood culturesCengiz et al. (2013), Turkey \[[@CR18]\]Diagnostic accuracy studyGeriatrics clinics11065--96N/ABacterial InfectionsFBC, biochemical parameters, CRP, serum protein electrophoresis, urine examination and Chest X-ray. Further tests (e.g. blood/urine/sputum/wound cultures, abdominal USS, chest and/or abdominal CT, MRI) performed as needed.Chou et al. (2016), Taiwan \[[@CR19]\]Retrospective observational study of diagnostic accuracyED986265 years and aboveN/ABacteraemiaBlood culturesDucharme et al., (2007), Canada \[[@CR20]\]Prospective observational study of diagnostic accuracyED10065 years and aboveN/AUTIUrine cultureDwolatzky et al. (2005), Israel \[[@CR21]\]Prospective observational study of diagnostic accuracyMedical Centre8065--101N/ABacteraemiaBlood culturesEvans et al. (1991), United Kingdom \[[@CR22]\]Diagnostic accuracy studyDay Hospital5065--93N/AUTIMid-stream urineJuthani-Mehta et al. (2007), USA \[[@CR23]\]Cohort studyFive nursing homes10165 years and above1 yearUTIPositive urine culture and greater than 10 white blood cells/mm^3^ on urinalysisLai et al. (2010), Taiwan \[[@CR24]\]Diagnostic accuracy studyED26265 years and aboveN/ABacteraemiaClinical infection and a positive blood culturePotts et al. (1999), USA \[[@CR25]\]Retrospective observational study of diagnostic accuracyED11780 years and aboveN/ACholecystitis, appendicitis and abscessSurgical diagnosisWasserman et al. (1989), USA \[[@CR26]\]Diagnostic accuracy studyED22170--99N/ABacterial infections1) Positive blood culture2) Positive urine culture and pyuria3) Positive sputum culture and infiltrate on Chest X-ray4) Positive culture from a normally sterile site or from an abscess cavity.*Abbreviations*: *CRP* C-reactive protein, *CT* Computerised tomography, *ESR* Erythrocyte sedimentation rate, *MRI* Magnetic Resonance Imaging, *N/A* Not applicable, *USS* Ultrasound Scan, *UTI* Urinary Tract Infection

Risk of Bias {#Sec9}
------------

Overall, the 11 studies were of moderate quality (See Figs. [2](#Fig2){ref-type="fig"} and [3](#Fig3){ref-type="fig"}). All had good applicability of the index test. Most studies had an unclear risk of bias due to lack of documentation of whether the index test had been interpreted without knowledge of the result of the reference standard, and vice versa.Fig. 2Risk of bias graph. Legend QUADAS-2 Risk of bias and applicability graph showing review authors' judgements about each domainFig. 3Risk of bias summary. Legend - QUADAS-2 Risk of bias and applicability summary showing review authors' judgements about each domain

Biomarkers {#Sec10}
----------

We calculated the diagnostic accuracy of 51 biomarkers. Figures [4](#Fig4){ref-type="fig"}a-d show the likelihood ratios and pre- and post-test probabilities of these biomarkers, categorized by bacterial infection. Two-by-two table data is presented in Additional file [3](#MOESM3){ref-type="media"}.Fig. 4Likelihood ratios and probability plot for diagnostic tests in diagnosing different bacterial infections. Legend -- **a**--**d** show likelihood ratios and pre- and post-test probabilities for diagnostic tests in diagnosing different bacterial infections. When possible, age-specific estimates have been given. When not specified, the result applies to patients aged 65 years and above. The figures have been separated according to the type of bacterial infection under investigation. Positive and negative likelihood ratios with 95% confidence intervals are presented for each test. The black dot within the dumbbell plot represents the pre-test probability of infection (i.e. disease prevalence). The red dot represents the probability of the infection after a positive test, and the green dot represents the probability of infection after a negative test. **c** -- Estimates derived from people aged 80 years and above. **d** -- CRP \> 4.355 mg/L and WBC \> 8,500/mm^3^ derived from people aged 65 years and above. All other estimates derived from people aged 70 years and above

Bacteraemia {#Sec11}
-----------

There were five estimates for procalcitonin (PCT) across three studies \[[@CR17], [@CR21], [@CR24]\]. Varying cut-off thresholds were used, ranging from a PCT of \> 0.2 ng/mL to ≥2.0 ng/mL. Figure [4](#Fig4){ref-type="fig"}a shows that having an elevated PCT (\> 0.2 ng/mL) helped to diagnose bacteraemia in older adults \[+ve LR range 1.50 to 2.60\] and raised the probability of bacteraemia by between 5% (PCT \> 0.2 ng/mL) \[[@CR17]\] and 17% (PCT \> 0.38 ng/mL) \[[@CR24]\]. However, only two of five estimates found that PCT was a useful rule-out test \[[@CR21], [@CR24]\]. Abnormal white blood cell (WBC) count were generally modest \[[@CR19]\] to unhelpful \[[@CR17]\] for ruling in or out bacteraemia (Fig. [4](#Fig4){ref-type="fig"}a). There were two estimates of CRP levels in relation to bacteraemia \[[@CR21]\]. A CRP ≥ 50 mg/L, helped to diagnose bacteraemia but only raised the probability of bacteraemia by 5% (Fig. [4](#Fig4){ref-type="fig"}a). Having a CRP ≥ 5 mg/L reduced the probability of bacteraemia by 1%.

Urinary tract infection (UTI) {#Sec12}
-----------------------------

A urine dipstick positive for nitrites or leucocytes (or in combination), as well as blood, were helpful in making a diagnosis of UTI (+ve LR range 1.23 to 54.90). Four of the five estimates found that absence of these findings on dipstick was a helpful rule out test (−ve LR range 0.06 to 0.46). One study effect size was large \[[@CR22]\] and the confidence interval was wide \[+ve LR 54.90 (95% CI 3.5 to 861.29)\] due to the small number of false positives and relatively small sample size; this result should be interpreted with caution. Protein on urine dipstick was not helpful \[[@CR22]\].

One small pilot study (*n* = 23) \[[@CR16]\] assessed urinary anti-microbial peptides for diagnosing UTI and suggested they may be useful (See Fig. [4](#Fig4){ref-type="fig"}b).

Intra-abdominal infection {#Sec13}
-------------------------

One study \[[@CR25]\], published in 1999, assessed the association between WBC count and surgical intra-abdominal infection. Figure [4](#Fig4){ref-type="fig"}c shows that a WBC \> 15.5 cells/mm^3^ led to a + ve LR 2.62 (95% CI 1.11--6.19), but only increased the probability of appendicitis by 3%. An elevated WBC count was not helpful in diagnosing cholecystitis or intra-abdominal abscess, nor was a normal WBC count useful in ruling out intra-abdominal infections (Fig. [4](#Fig4){ref-type="fig"}c).

Bacterial infections {#Sec14}
--------------------

Two studies \[[@CR18], [@CR26]\] assessed the utility of blood tests in diagnosing multiple infections grouped together, mostly of bacterial aetiology (including Pneumonia, UTI, sepsis and bacteraemia). One study \[[@CR18]\] assessed patients in a geriatrics clinic with an elevated ESR ≥ 80 mm/h and found that a CRP \> 4.36 mg/L or a leucocyte count \> 8,500/mm^3^ was not helpful in diagnosing bacterial infections (see Fig. [4](#Fig4){ref-type="fig"}d). The other study \[[@CR26]\] assessed full blood count and peripheral blood smear for diagnosing bacterial infections in older adults in the ED. They found an elevated WBC count, elevated bands, elevated neutrophils, elevated polymorphonuclear leucocytes (PMNs) and the presence of Dӧhle bodies were all generally helpful in diagnosing and ruling out bacterial infection. These tests raised the probability of bacterial infection by up to 56% \[[@CR26]\] (see Fig. [4](#Fig4){ref-type="fig"}d).

Discussion {#Sec15}
==========

Summary {#Sec16}
-------

The results of our review were limited by many of the studies having small sample sizes apart from one, the moderate quality, and the limitation to mainly emergency departments. The results do suggest though that an elevated PCT may be a useful test for bacteraemia in primary care, but an abnormal WBC count and elevated CRP are less helpful. A positive urine dipstick may help to diagnose UTI, and there is some evidence that urinary anti-microbial peptides may be helpful. Whereas an elevated WBC count may be helpful in diagnosing appendicitis, it is not of use in diagnosing cholecystitis or intra-abdominal abscess, nor is a normal WBC a useful rule-out test for intra-abdominal infection.

Comparison with existing literature {#Sec17}
-----------------------------------

Our findings are similar to a previous systematic review by Lee et al \[[@CR27]\] that assessed the utility of PCT in diagnosing sepsis in older adults. They included four studies, two of which \[[@CR16], [@CR17]\], are included in this review and two further studies \[[@CR28], [@CR29]\] that were conducted in the inpatient setting. Overall, they found that PCT may have some value in diagnosing bacterial sepsis \[+ve LR 4.77, 95% CI: 2.49--9.13\], but not as a standalone test \[[@CR27]\]. It is important to note that PCT levels can be affected by co-morbid conditions such as chronic kidney disease \[[@CR30]\]. Two included studies \[[@CR17], [@CR24]\] excluded certain participants (patients consuming antibiotics in the preceding 48 h, and pre-existing thyroid disease, respectively) to try to minimise this confounding.

A further systematic review \[[@CR4]\] assessing clinical predictors of UTI in older adults, haematuria was found to help to diagnose UTI in men, but not in women. This was felt to be related to high levels of atrophic vaginitis in older women \[[@CR31]\], which may lead to cross-contamination of urine dipsticks. In the study by Evans et al \[[@CR22]\], in which blood on urine dipstick was helpful in diagnosing a UTI, the majority of participants were women (76%). However, our review includes only one estimate of the utility of blood on urine dipstick. Further studies assessing this test are needed to confirm or refute this finding.

Comparison with existing guidelines {#Sec18}
-----------------------------------

SIGN guidelines for UTI in older adults advise against the use of the urine dipstick as a diagnostic test \[[@CR9]\] due to lack of high quality evidence. This advice is echoed by Public Health England guidance \[[@CR32]\], because positive urine dipsticks are often be caused by asymptomatic bacteriuria. The results of our review contradict these recommendations, and suggest that a positive urine dipstick for nitrites and leucocytes is helpful in diagnosing UTI in symptomatic older adults. Further studies in this area are required to corroborate or refute these findings.

Strengths and limitations {#Sec19}
-------------------------

To our knowledge, this is the first systematic review assessing the utility of biomarkers in diagnosing bacterial infections in older adult outpatients. Our search strategy was broad so that we could capture as many relevant results as possible. We included studies that were published in all languages and translated eligible non-English language studies.

However, due to the breadth of this review, it is likely that we have missed some relevant studies, particularly unpublished studies. Most of the studies had small sample sizes, and this may have led to spurious results. Due to insufficient numbers of included studies and heterogeneity in the thresholds used as cut-offs to determine test positivity, we were unable to pool the results.

One study \[[@CR18]\] included infections that did not fall within our inclusion criteria (e.g. septic arthritis). However, Pneumonia, UTI and sepsis accounted for 85% of the infections assessed, and we therefore believe that the findings are relevant to this review.

We do not have a 'perfect' gold standard for diagnosing UTI in older adults; high levels of asymptomatic bacteriuria in older adults means that a positive urine culture does not always represent a UTI. We tried to mitigate this issue by including studies of UTI in symptomatic participants. However, it is possible that a positive urine dipstick result correlates with a positive MSU rather than with the diagnosis of a true UTI.

We are also aware that statistical significance of a test on the basis of a likelihood ratio may not be clinically significant. It is, therefore, useful to interpret likelihood ratios in the context of prior probability using the probability plots.

Incorporation bias is largely unavoidable in studies of diagnostic tests, as clinicians often make diagnoses through combining the results of more than one test and clinical assessment. A single test combined with other information may help to make a diagnosis, but is unlikely to rule in or out a diagnosis in isolation.

It is also possible for confounding to arise through a patient having two bacterial infections, such as bacteraemia and an intra-abdominal infection. The index test might therefore be elevated due to either, or both, of the infections.

Implications for future research {#Sec20}
--------------------------------

Few of the studies in this review assessed the utility of combinations of tests; this would be useful in future studies and would allow the development of clinical prediction tools that could be used by clinicians. It would be helpful if these studies used the same or similar thresholds for determining test positivity to facilitate pooling of results. We did not find any eligible studies assessing the utility of biomarkers for diagnosing Pneumonia; research to fill this evidence gap is needed. SIGN guidance recognises that the gold standard for diagnosing UTI in older adults (Urine culture) is imperfect due to high levels of asymptomatic bacteriuria in this age group \[[@CR6], [@CR8]\]. We therefore need an alternative gold standard for UTI in older adults. The use of urinary anti-microbial peptides may be promising; further research in this area and assessing other novel tests for UTI in older adults is advised.

Implications for clinical practice {#Sec21}
----------------------------------

The evidence from this review suggests some blood and urinary biomarkers are helpful for diagnosing bacterial infections in older adults in the community. However, these findings should be interpreted with caution because they come from a limited number of mostly small studies of moderate quality.

Conclusions {#Sec22}
===========

The limited evidence of moderate quality suggests that an elevated PCT may be helpful for diagnosing bacteraemia, a positive urine dipstick may be helpful in diagnosing UTI. Although an elevated WBC count has limited utility in diagnosing intra-abdominal infections, it may have utility, along with elevated WBC differentials, in differentiating bacterial infections from other acute illness. Further studies of high quality are urgently needed in this area.

Additional files
================

 {#Sec23}

Additional file 1:PRISMA checklist. (DOCX 26 kb) Additional file 2:Search strategy. (DOCX 22 kb) Additional file 3:**Table S1.** Legend Two by two tables with sensitivities, specificities and their 95% confidence intervals. (PPTX 53 kb)

+ve LR

:   Positive likelihood ratio

CAP

:   Community acquired pneumonia

CRP

:   C-reactive protein

CT

:   Computerised tomography

ED

:   Emergency department

ESR

:   Erythrocyte sedimentation rate

MRI

:   Magnetic Resonance Imaging

N/A

:   Not applicable

PCT

:   Procalcitonin

PMN

:   Polymorphonuclear leucocyte

PRISMA

:   Preferred Reporting Items for Systematic Reviews and Meta-Analyses

QUADAS-2

:   Quality Assessment of Diagnostic Accuracy Studies-2

SIGN

:   Scottish Intercollegiate Guidelines Network

USS

:   Ultrasound

UTI

:   Urinary Tract Infection

-ve LR

:   Negative likelihood ratio

WBC

:   White blood cell
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